The Trump administration is expected to link autism to Tylenol use during pregnancy

['Jon Hamilton', '.Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow', 'Class', 'Wp-Block-Co-Authors-Plus', 'Display Inline', '.Wp-Block-Co-Authors-Plus-Avatar', 'Where Img', 'Height Auto Max-Width', 'Vertical-Align Bottom .Wp-Block-Co-Authors-Plus-Coauthors.Is-Layout-Flow .Wp-Block-Co-Authors-Plus-Avatar', 'Vertical-Align Middle .Wp-Block-Co-Authors-Plus-Avatar Is .Alignleft .Alignright'] TPR: The Public's Radio 2025-09-22 17:08:06

(Alex Wong | Getty Images)The Trump administration is expected to assert later today that use of acetaminophen — the active ingredient in Tylenol — can increase the risk of autism when used during pregnancy, despite the fact that scientific research has not conclusively demonstrated a causal link. White House officials are also expected to suggest that a form of vitamin B that is typically used in conjunction with cancer treatment could be used to treat autism. HHS responds to report about autism and acetaminophen A report that health secretary Robert F. Kennedy, Jr. has promised will come out this month will look at the causes of autism. Autism has long been a target for Health and Human Services Secretary Robert F. Kennedy Jr. In addition, scientists agree that genetics play a central role in a child’s risk of developing autism.